A Review of Acute Rescue Therapies in Clinical Practice

A Review of Acute Rescue Therapies in Clinical Practice

SKU: CEI-A-REVIEW-OF–1778990400-PODCAS-PH-10175
9.00 USD In stock Buy at Merchant

Acute rescue medications are critical in time-sensitive emergencies, and pharmacists play an essential role in ensuring patients and caregivers are prepared to use them correctly. This course discusses the roles of glucagon, naloxone, and epinephrine, including recent updates on novel formulations and device innovations that are reshaping emergency response in community settings. You will gain practical insights to strengthen counseling, improve readiness, and support optimal outcomes when seconds matter most. Upon successful completion of this course, pharmacists should be able to: 1. Describe the mechanisms of action and primary indications for glucagon, naloxone, and epinephrine as acute rescue medications. 2. Summarize recent updates for glucagon, naloxone, and epinephrine that impact pharmacist counseling and patient access. Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls Wendy Mobley-Bukstein, PharmD, BCACP, CDCES, CHWC, NASM-CPT Professor of Pharmacy Practice Drake University CPHS Rachel Maynard has no relevant financial relationships with ineligible companies to disclose. Wendy Mobley-Bukstein is a Diabetes Care Speaker for Abbott. All relevant financial relationships have been mitigated. Course fee includes course materials and CPE credit submission to CPE Monitor. Course is non-refundable. Release Date: May 18, 2026 Planned Expiration Date: May 18, 2027 Recording, capturing, or sharing any part of this presentation is strictly prohibited. This includes the use of AI note-taking tools, audio/video devices, or screen capture technology. Please help us protect the privacy of our speakers and the integrity of the educational content. Copyright 2026, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden. Universal Activity Number (UAN): 0107-0000-26-131-H01-P Application-based CPE Activity Release Date: May 16, 2026 Planned Expiration Date: May 17, 2027 CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net. ¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.

Specifications
Duration
30m
CEUs
0.05
Target Role
Pharmacist

AI Readiness

Good foundation, but some important product data is still missing.

75%